Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body

NCT02201797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2015-06-24

No results posted yet for this study

Summary

Advanced MRI (Magnetic Resonance Imaging) technique called DCE (Dynamic Contrast Enhanced) and DWI MRI can provide valuable information regarding tumor biology and response to treatment through various parameters. Validating stability of these parameters will further establish robustness and reliability of these promising biomarkers.

Conditions

  • Metastatic Liver Cancer

Interventions

OTHER

DCE MRI

Sponsors & Collaborators

  • Bracco Diagnostics, Inc

    collaborator INDUSTRY
  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Kyung Won Kim, M.D. · Asan Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02201797 on ClinicalTrials.gov